Life back in
motion.

Putting innovation, creativity and excellence at the service of cardiology.

Addressing a critical health challenge

Severe and irreversible right ventricular dysfunction, though rare, poses a life-threatening challenge—highlighting the critical need for effective medical interventions. Today, patients with right-sided heart failure are left with limited options, making innovative solutions more urgent than ever. The current medical devices and procedures available are invasive and require major surgery, aside from the fact that recovery is both cumbersome and never complete.

Today, thousands of people across Europe and the United States struggle with right heart dysfunction. Whether due to a congenital condition treated with FONTAN surgery or other causes, these patients face a critical lack of sustainable solutions—leaving them without the chance for a longer, healthier life. It’s time for innovation to change that.

Closing the therapeutic gap with a word-class team

Recognizing this critical therapeutic gap, we are taking action to deliver a real solution for doctors, patients, and their families.

Over the past four years, we have assembled a world-class team of top physicians and engineers—selected for their expertise, proven experience, and unwavering dedication. This multidisciplinary team collaborates daily, combining their skills to develop a groundbreaking, minimally invasive, percutaneous, and long-lasting device that will redefine the future of right heart treatment.

Developing a groundbreaking medical device requires excellence, speed, and a spirit of collaboration. That’s why Brightflow has united a world-class team with a clear mission: to transform the lives of patients with right heart failure—helping them live longer, healthier, and better.